NCT00254774View on ClinicalTrials.gov

Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

March 31, 2006

Conditions
Bipolar Disorder
Interventions
DRUG

quetiapine fumarate or valproate

Trial Locations (3)

Unknown

Research Site, Berlin

Research Site, Freiburg im Breisgau

Research Site, München

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY